Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid

Pediatric Infectious Disease Journal

Volumn 16, Issue 7, 1997, Pages 667-674

  Sigurdardottir, Sigurveig T ^b   Vidarsson, Gestur ^b   Gudnason, Thorolfur ^b   Kjartansson, Sveinn ^b   Kristinsson, Karl G ^b   Jonsson, Steinn ^b   Valdimarsson, Helgi ^b   Schiffman, Gerald ^b   Schneerson, Rachel ^b   Jonsdottir, Ingileif ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b NONE

Author keywords

Colonization; Conjugate vaccine; Immunogenicity; Infants; Opsonization; Pneumococcus; Safety

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; ERYTHEMA; HUMAN; IMMUNOGENICITY; INFANT; OPSONIZATION; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFANT; MALE; NASOPHARYNX; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; SALIVA; STREPTOCOCCUS PNEUMONIAE; TETANUS TOXOID; VACCINATION; VACCINES, CONJUGATE;

EID: 0030793978     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199707000-00009     Document Type: Article

References (43)

1. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland [see comments]. JAMA 1992;268: 3323-7.
2. Dagan R, Engelhard D, Piccard E. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group [see comments]. [Published erratum appears in JAMA 1994;272:1006; Englehard D, corrected to Engelhard, D]. JAMA 1992;268:3328-32.
3. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era [see comments]. JAMA 1993;269:221-6.
4. Gudbjörnsson B, Thorsteinsson SB, Kristinsson KG, et al. [Pneumonia]. Icelandic Med J 1987;73:359-63.
5. Giebink GS. Preventing pneumococcal disease in children: recommendations for using pneumococcal vaccine [Review]. Pediatr Infect Dis 1985;4:343-8.
6. Giebink GS. The microbiology of otitis media [Review]. Pediatr Infect Dis J 1989;8(Suppl 1):S18-20.
7. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis 1994;169:212-4.
8. Austrian R, Howie VM, Ploussard JH. The bacteriology of pneumococcal otitis media. Johns Hopkins Med J 1977;141: 104-11.
9. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview [Review]. Clin Infect Dis 1992;15: 77-83.
10. Kristinsson KG, Hjalmarsdottir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland [Letter]. Lancet 1992;339:1606-7.
11. Kristinsson KG. The epidemiology of penicillin-resistant pneumococci [in Swedish]. Nord Med 1996;111:103-8.
12. Åhman H, Käyhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996;15: 134-9.
13. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996;128:649-53.
14. Makela PH, Leinonen M, Pukander J, Karma P. A study of the pneumococcal vaccine in prevention of clinically acute attacks of recurrent otitis media. Rev Infect Dis 1981;Suppl 3:S124-32.
15. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
16. Leinonen M, Sakkinen A, Kalliokoski R, Luotonen J, Timonen M, Makela, PH. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis 1986;5:39-44.
17. Musher DM, Chapman AJ, Goree A, Jonsson S, Briles D, Baughn RE. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis 1986;154:245-56.
18. Watson DA, Musher DM, Verhoef J. Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis 1995;14:479-90.
19. Vidarsson G, Jonsdottir I, Jonsson S, Valdimarsson H. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J Infect Dis 1994;170: 592-9.
20. Bardardottir E, Jonsson S, Jonsdottir I, Sigfusson A, Valdimarsson H. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. J Infect Dis 1990;162:482-8.
21. Lortan JE, Kaniuk AS, Monteil MA. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin Exp Immunol 1993;91:54-7.
22. Musher DM, Johnson B, Jr., Watson DA. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun 1990;58:3871-6.
23. Alonso De Velasco E, Dekker BA, et al. Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice. J Infect Dis 1995;172:562-5.
24. Aaberge IS, Eng J, Lermark G, Lovik M. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog 1995;18:141-52.
25. Robbins JB, Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines [see comments] [Review]. J Infect Dis 1990;161:821-32.
26. Schneerson R, Robbins JB, Parke JC, Jr., et al. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and Pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun 1986;52:519-28.
27. Jonsdottir KE, Steingrimsson O, Olafsson O. Immunisation of infants in Iceland against Haemophilus influenzae type b [Letter]. Lancet 1992;340:252-3.
28. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324: 1767-72.
29. Eskola J, Kayhty H, Takala AK, et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease [see comments]. N Engl J Med 1990;323(20):1381-7.
30. Sarnaik S, Kaplan J, Schiffman G, Bryla D, Robbins JB, Schneerson R. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two-to five-year-old children with sickle cell anemia [published erratum appears in Pediatr Infect Dis J 1990;9:308]. Pediatr Infect Dis J 1990;9:181-6.
31. Giebink GS, Koskela M, Vella PP, Harris M, Le CT. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media. J Infect Dis 1993;167:347-55.
32. Kronvall G. A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci. J Med Microbiol 1973;6:187-90.
33. Schiffman G, Douglas RM, Bonner MJ, Robbins M, Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines: I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods 1980;33:133-44.
34. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations [Review]. Rev Infect Dis 1981;3(Suppl):S184-97.
35. Nahm MH, Siber GR, Olander JV. A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides. J Infect Dis 1996;173:113-8.
36. Claesson BA, Schneerson R, Robbins JB, etal. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr 1989;114:97-100.
37. Schneerson R, Robbins JB, Chu C, et al. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect Immun 1984;45:582-91.
38. Barington T, Gyhrs A, Kristensen K, Heilmann C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994;62: 9-14.
39. Granoff DM, Holmes SJ, Belshe RB, Osterholm MT, McHugh, JE, Anderson EL. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. JAMA 1994;272:1116-21.
40. Robbins JB, Schneerson R, Szu SC. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum [Review]. J Infect Dis 1995;171:1387-98.
41. Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995;171:93-8.
42. Kauppi M, Eskola J, Kayhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J 1995;14:286-94.
43. Kayhty H, Ahman H, Ronnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995;172:1273-8.